RARE
Ultragenyx Pharm (RARE)
NASDAQ
$25.15+$0.24 (+0.98%)
Price as of Aug 03, 2026 8:53 AM EDT
  • $2.5B
    Market Cap
  • -12.41%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 38
Valuation
RARE
vs History
vs S&P 500
Profitability
-0
Growth
-1
Low Earnings Volatility
3

Momentum Score

Score: 32
Valuation
RARE
vs History
vs S&P 500
3-Month Momentum
32.00%
12-Month Momentum
18.52%
3-Month Risk Adjusted Momentum
138.62%
12-Month Risk Adjusted Momentum
28.24%

True Yield

N/A
Valuation
RARE
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.08%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 44
Valuation
RARE
vs History
vs S&P 500
Ohlson's O-Score
6